Please enable JS

Investor Overview

Corporate Profile

Zai Lab (NASDAQ: ZLAB) is a Shanghai-based innovative biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. The company’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast growing segments of China’s pharmaceutical market and global unmet medical needs. Zai Lab’s vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partner’s and its own products in order to impact human health worldwide.

Stock Quote
 - 0.08 (0.49%)

Stock chart for: ZLAB.OQ.  Currently trading at $16.39 with a 52 week high of $32.34 and a 52 week low of $14.29.
Data as of October 17, 2018 12:51 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delay
Refresh quote

Upcoming Events

There are currently no events scheduled.

E-mail alerts

Sign up to receive e-mail alerts whenever Zai Lab Limited posts new information to the site. Just enter your e-mail address and click Submit.